PD-1 antibody therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PD-1 antibody therapy, covering 2024-11-18 to 2026-01-08. Get the full timeline:
Most recent: Clinical Trial Update: PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma [Phase 2]